Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ELTX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
7 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
48 filers reported a long position in ELTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Knoll Capital Management, LLC | $4.7M | 1.2M | +92.1% |
| BlackRock, Inc. | $3M | 766K | +1,413.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.2M | 572.2K | +10.3% |
| GEODE CAPITAL MANAGEMENT, LLC | $1.2M | 311.4K | +130.4% |
| STATE STREET CORP | $701.5K | 179.4K | +254.4% |
| NORTHERN TRUST CORP | $508.9K | 130.2K | +117.9% |
| Ikarian Capital, LLC | $391K | 100K | New |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $347.6K | 88.9K | New |
| VANGUARD FIDUCIARY TRUST CO | $344.3K | 88.1K | +27.3% |
| ALLIANCEBERNSTEIN L.P. | $317.8K | 81.3K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.